ImmunoGen, Inc. carries a market capitalization of 8.73B, placing it among publicly traded companies globally.
| Market Cap | 8.73B |
| Enterprise Value | N/A |
ImmunoGen, Inc.'s stock has gained approximately 726.32275% over the past 52 weeks. The 50-day moving average sits at 29.04, while the 200-day moving average is 18.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | 726.32275% |
| 50-Day Moving Average | 29.04 |
| 200-Day Moving Average | 18.87 |
| Average Volume (20 Days) | N/A |